Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Experimental Dermatology|March 19, 2016
Biphasic increase in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga miceYoshihito Yamada, Yuhki Ueda, Aki Nakamura, et al.The Journal of Investigative Dermatology|July 23, 2025
A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic EvaluationKen Okamura, Yosuke Arai, Junnosuke Kawaguchi, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 11, 2011
Relationship between sleep duration and clustering of metabolic syndrome diagnostic componentsSayuri Katano, Yasuyuki Nakamura, Aki Nakamura, et al.Journal of Diabetes Investigation|May 21, 2014
Association of short sleep duration with impaired glucose tolerance or diabetes mellitusSayuri Katano, Yasuyuki Nakamura, Aki Nakamura, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 11, 2011
Relationship between health-related quality of life and clustering of metabolic syndrome diagnostic componentsSayuri Katano, Yasuyuki Nakamura, Aki Nakamura, et al.Acta Oto-Laryngologica. Supplementum|October 30, 2004
A case of simultaneous primary carcinomas of the tongueMakoto Kusuki, Hiroyoshi Iguchi, Aki Nakamura, et al.Regenerative Therapy|July 19, 2021
Prenatal enzyme replacement therapy for Akp2 -/- mice with lethal hypophosphatasiaAkihiro Hasegawa, Aki Nakamura-Takahashi, Masataka Kasahara, et al.Pediatrics and Neonatology|May 22, 2026
Novel susceptible human leukocyte antigens allele in juvenile dermatomyositis: A study in Japanese patientsYuichi Yamasaki, Tomo Nozawa, Shouichirou Kusunoki, et al.European Journal of Pharmacology|July 16, 2011
Activation of lipoprotein lipase increases serum high density lipoprotein 2 cholesterol and enlarges high density lipoprotein 2 particles in ratsMasataka Kusunoki, Kazuhiko Tsutsumi, Daisuke Sato, et al.European Journal of Pharmacology|August 13, 2011
Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886Masataka Kusunoki, Kazuhiko Tsutsumi, Daisuke Sato, et al.Pageof 6